4-Cyclohexene-1,3-diol, 5-[(1Z)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-, (1R,3S)-

4-Cyclohexene-1,3-diol, 5-[(1Z)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-, (1R,3S)- Struktur
125732-36-7
CAS-Nr.
125732-36-7
Englisch Name:
4-Cyclohexene-1,3-diol, 5-[(1Z)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-, (1R,3S)-
Synonyma:
Doxercalciferol Impurity 17;4-Cyclohexene-1,3-diol, 5-[(1Z)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-, (1R,3S)-
CBNumber:
CB19269920
Summenformel:
C28H44O3
Molgewicht:
428.65
MOL-Datei:
125732-36-7.mol

4-Cyclohexene-1,3-diol, 5-[(1Z)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-, (1R,3S)- Eigenschaften

Siedepunkt:
577.2±50.0 °C(Predicted)
Dichte
1.120±0.06 g/cm3(Predicted)
pka
14.25±0.70(Predicted)

Sicherheit

4-Cyclohexene-1,3-diol, 5-[(1Z)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-, (1R,3S)- Chemische Eigenschaften,Einsatz,Produktion Methoden

4-Cyclohexene-1,3-diol, 5-[(1Z)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-, (1R,3S)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


4-Cyclohexene-1,3-diol, 5-[(1Z)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-, (1R,3S)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Shandong Wadesen Biotechnology Co. LTD 0531-88723173 18596073690
1047208234@qq.com China 3605 58
Changzhou Bojia Biomedical Technology Co., Ltd. 2122619822
czbjpharma@126.com China 18488 58
Suzhou Haiben Pharmaceutical Co., Ltd 14760821013 14760821013
1816280386@qq.com China 9036 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
3287908757@qq.com China 9887 58

  • 4-Cyclohexene-1,3-diol, 5-[(1Z)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-, (1R,3S)-
  • Doxercalciferol Impurity 17
  • 125732-36-7
Copyright 2019 © ChemicalBook. All rights reserved